YPEL3, a p53-regulated gene that induces cellular senescence.
Cellular senescence, the limited ability of cultured normal cells to divide, can result from cellular damage triggered through oncogene activation (premature senescence) or the loss of telomeres following successive rounds of DNA replication (replicative senescence). Although both processes require a functional p53 signaling pathway, relevant downstream p53 targets have been difficult to identify. Discovery of senescence activators is important because induction of tumor cell senescence may represent a therapeutic approach for the treatment of cancer. In microarray studies in which p53 was reactivated in MCF7 cells, we discovered that Yippee-like-3 (YPEL3), a member of a recently discovered family of putative zinc finger motif coding genes consisting of YPEL1-5, is a p53-regulated gene. YPEL3 expression induced by DNA damage leads to p53 recruitment to a cis-acting DNA response element located near the human YPEL3 promoter. Physiologic induction of YPEL3 results in a substantial decrease in cell viability associated with an increase in cellular senescence. Through the use of RNAi and H-ras induction of cellular senescence, we show that YPEL3 activates cellular senescence downstream of p53. Consistent with its growth suppressive activity, YPEL3 gene expression is repressed in ovarian tumor samples. One mechanism of YPEL3 downregulation in ovarian tumor cell lines seems to be hypermethylation of a CpG island upstream of the YPEL3 promoter. We believe these findings point to YPEL3 being a novel tumor suppressor, which upon induction triggers a permanent growth arrest in human tumor and normal cells.
Kelley
Kevin D
KD
Biochemistry & Molecular Biology Department, Wright State University, Dayton, Ohio 45435, USA.
Miller
Kelly R
KR
Todd
Amber
A
Kelley
Amy R
AR
Tuttle
Rebecca
R
Berberich
Steven J
SJ
D045744:Cell Line, Tumor; D016922:Cellular Senescence / Q000235:genetics; D018899:CpG Islands; D019175:DNA Methylation; D015972:Gene Expression Regulation, Neoplastic; D045325:HCT116 Cells; D056945:Hep G2 Cells; D006801:Humans; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D025521:Tumor Suppressor Proteins / Q000096:biosynthesis / Q000235:genetics*
C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D025521:Tumor Suppressor Proteins; C549565:YPEL3 protein, human
Nature. 2007 Feb 8;445(7128):661-5
17251932
Cell. 1997 Mar 7;88(5):593-602
9054499
Aging (Albany NY). 2009 Jan;1(1):89-108
19946469
Cell. 2005 Feb 25;120(4):513-22
15734683
BMC Bioinformatics. 2007 Mar 08;8 Suppl 1:S20
17430565
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8467-72
12077306
Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9363-7
7568133
Oncogene. 2004 Dec 9;23(57):9238-46
15489886
Gene. 2004 Sep 29;340(1):31-43
15556292
Cancer Res. 2003 Feb 1;63(3):705-12
12566317
Mol Cell. 2003 Mar;11(3):552-4
12667439
Insect Mol Biol. 2001 Feb;10(1):77-86
11240639
Mol Cell. 2003 Mar;11(3):577-90
12667443
Oncogene. 2008 Nov 6;27(52):6657-66
18711402
Cell. 2009 May 1;137(3):413-31
19410540
Mol Cancer Res. 2009 Sep;7(9):1497-509
19737973
Oncogene. 1999 Sep 2;18(35):4974-82
10490832
Science. 1997 Aug 8;277(5327):831-4
9242615
Nat Cell Biol. 2006 Aug;8(8):877-84
16862142
Cell. 2003 Jun 13;113(6):703-16
12809602
Nature. 2007 Feb 8;445(7128):656-60
17251933